Foundation Radiology Group PC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Foundation Radiology Group PC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10811
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation Radiology Group PC (FRG) is a provider of radiology solutions. The company offers radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It offers imaging solutions for the radiologists and systems to the existing radiology department. FRG’s solutions comprise programmatic strategic alignment, multi-dimensional and tightly-integrated elite team solutions. The company provides on-site radiology and teleradiology solutions for hospital institutions and outpatient imaging centers. It serves hospitals in the Northeast, Eastern Midwest and East Coast regions of the US. FRG is headquartered in Pittsburgh, Pennsylvania, the US.

Foundation Radiology Group PC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Foundation Radiology Group PC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Foundation Radiology Group PC, Medical Devices Deals, 2012 to YTD 2018 8
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Foundation Radiology Raises USD2.5 Million in Venture Financing 10
Foundation Radiology Raises US$0.5 Million In Venture Financing 11
Foundation Radiology Raises Additional US$0.04 Million In Venture Financing 12
Foundation Radiology Raises Additional US$1 Million In Venture Financing 13
Foundation Radiology Group Raises US$0.2 Million In Venture Financing 14
Foundation Radiology Group PC – Key Competitors 15
Foundation Radiology Group PC – Key Employees 16
Foundation Radiology Group PC – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Jan 11, 2018: Foundation Radiology Group Announces New Board Member Kraig McEwen 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Key Facts 2
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Foundation Radiology Group PC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Foundation Radiology Group PC, Medical Devices Deals, 2012 to YTD 2018 8
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Foundation Radiology Raises USD2.5 Million in Venture Financing 10
Foundation Radiology Raises US$0.5 Million In Venture Financing 11
Foundation Radiology Raises Additional US$0.04 Million In Venture Financing 12
Foundation Radiology Raises Additional US$1 Million In Venture Financing 13
Foundation Radiology Group Raises US$0.2 Million In Venture Financing 14
Foundation Radiology Group PC, Key Competitors 15
Foundation Radiology Group PC, Key Employees 16

List of Figures
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Foundation Radiology Group PC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Foundation Radiology Group PC, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Foundation Radiology Group PC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guess?, Inc.:戦略・SWOT・企業財務分析
    Guess?, Inc. - Strategy, SWOT and Corporate Finance Report Summary Guess?, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cotinga Pharmaceuticals Inc (COT):製薬・医療:M&Aディール及び事業提携情報
    Summary Cotinga Pharmaceuticals Inc (Cotinga), formerly Critical Outcome Technologies Inc, is a developer of targeted therapeutics with focus on oncology. The company offers pipeline products such as COTI-2 targeting p53 and COTI-259 targeting KRAS. Its research includes program, indication, screeni …
  • Agway Energy Services, LLC:企業の戦略的SWOT分析
    Agway Energy Services, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mauna Kea Technologies SAS (MKEA):企業の財務・戦略的SWOT分析
    Summary Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicro …
  • Torraspapel, S.A.:企業の戦略的SWOT分析
    Torraspapel, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Rheonix Inc:企業の製品パイプライン分析2018
    Summary Rheonix Inc (Rheonix) is a medical equipment company that develops molecular diagnostic products. The company offers automated and integrated molecular testing device. It develops Rheonix CARD cartridge technology which penetrates molecular testing markets from diagnostics labs to applied ma …
  • Topas Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Topas Therapeutics GmbH (Topas Therapeutics) is a biotechnological company that designs and develops nanoparticle products loaded with antigenic peptides. The company’s pre-clinical pipeline categories are used in the treatment of allergies, immune mediated diseases, autoimmune diseases, and …
  • QinetiQ Group plc:戦略・SWOT・企業財務分析
    QinetiQ Group plc - Strategy, SWOT and Corporate Finance Report Summary QinetiQ Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • AXA Life Insurance Co., Ltd.:企業の戦略・SWOT・財務情報
    AXA Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AXA Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Covance Inc:医療機器:M&Aディール及び事業提携情報
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • Medifast, Inc. (MED):企業の財務・戦略的SWOT分析
    Medifast, Inc. (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Novatek (NVTK):企業の財務・戦略的SWOT分析
    Novatek (NVTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Enzymotec Ltd:企業の戦略・SWOT・財務情報
    Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report Summary Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • L’Oreal SA:戦略・SWOT・企業財務分析
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Healthscope Ltd:企業の戦略的SWOT分析
    Healthscope Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • The Norinchukin Bank:企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Amryt Pharma plc (AMYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Amryt Pharma plc (Amryt) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include Lojuxta for the treatment of adult HoFH and Episalvan for the treatment of PTW. The …
  • CoreRx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CoreRx Inc (CoreRx) is a contract development manufacturing organization that provides a comprehensive range of drug development services. The company provides products portfolio such as oral, topical, liquids or parental, ophthalmic and combined medicines, among others. It provides a wide r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆